$38.24
0.42%
Downside
Day's Volatility :3.5%
Upside
3.09%
22.23%
Downside
52 Weeks Volatility :66.63%
Upside
57.09%
Period | Quidelortho Corp | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -3.53% | 6.5% | 0.0% |
6 Months | -45.65% | 7.1% | 0.0% |
1 Year | -56.67% | 9.8% | 0.0% |
3 Years | -72.63% | 14.2% | -20.2% |
Market Capitalization | 2.6B |
Book Value | $49.52 |
Earnings Per Share (EPS) | -26.38 |
PEG Ratio | 7.19 |
Wall Street Target Price | 54.6 |
Profit Margin | -61.65% |
Operating Margin TTM | 2.32% |
Return On Assets TTM | 1.32% |
Return On Equity TTM | -42.51% |
Revenue TTM | 2.9B |
Revenue Per Share TTM | 42.81 |
Quarterly Revenue Growth YOY | -16.0% |
Gross Profit TTM | 1.9B |
EBITDA | 620.3M |
Diluted Eps TTM | -26.38 |
Quarterly Earnings Growth YOY | -0.77 |
EPS Estimate Current Year | 1.96 |
EPS Estimate Next Year | 3.36 |
EPS Estimate Current Quarter | 0.39 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 42.78%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 522.3M | ↑ 88.05% |
Net Income | 74.2M | ↓ 1008.55% |
Net Profit Margin | 14.2% | ↑ 17.14% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 534.9M | ↑ 2.41% |
Net Income | 72.9M | ↓ 1.7% |
Net Profit Margin | 13.63% | ↓ 0.57% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.7B | ↑ 210.66% |
Net Income | 810.3M | ↑ 1011.18% |
Net Profit Margin | 48.76% | ↑ 35.13% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.7B | ↑ 2.22% |
Net Income | 704.2M | ↓ 13.09% |
Net Profit Margin | 41.46% | ↓ 7.3% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 3.3B | ↑ 92.28% |
Net Income | 548.7M | ↓ 22.08% |
Net Profit Margin | 16.8% | ↓ 24.66% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.0B | ↓ 8.34% |
Net Income | -10.1M | ↓ 101.84% |
Net Profit Margin | -0.34% | ↓ 17.14% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 866.5M | ↑ 10.55% |
Net Income | 30.3M | ↑ 57.81% |
Net Profit Margin | 3.5% | ↑ 1.05% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 846.1M | ↓ 2.35% |
Net Income | 48.8M | ↑ 61.06% |
Net Profit Margin | 5.77% | ↑ 2.27% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 665.1M | ↓ 21.39% |
Net Income | -53.2M | ↓ 209.02% |
Net Profit Margin | -8.0% | ↓ 13.77% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 744.0M | ↑ 11.86% |
Net Income | -12.7M | ↓ 76.13% |
Net Profit Margin | -1.71% | ↑ 6.29% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 742.6M | ↓ 0.19% |
Net Income | 7.0M | ↓ 155.12% |
Net Profit Margin | 0.94% | ↑ 2.65% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 709.7M | ↓ 4.43% |
Net Income | -1.7B | ↓ 24471.43% |
Net Profit Margin | -240.38% | ↓ 241.32% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 806.4M | ↓ 13.78% |
Total Liabilities | 380.8M | ↓ 46.23% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 910.9M | ↑ 12.96% |
Total Liabilities | 351.0M | ↓ 7.81% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.9B | ↑ 105.43% |
Total Liabilities | 538.5M | ↑ 53.39% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.4B | ↑ 29.89% |
Total Liabilities | 501.0M | ↓ 6.95% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 8.9B | ↑ 264.38% |
Total Liabilities | 3.9B | ↑ 682.66% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 8.6B | ↓ 3.31% |
Total Liabilities | 3.6B | ↓ 9.28% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 8.9B | ↑ 2.31% |
Total Liabilities | 3.9B | ↑ 1.58% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 8.8B | ↓ 0.78% |
Total Liabilities | 3.8B | ↓ 3.33% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 8.6B | ↓ 2.69% |
Total Liabilities | 3.5B | ↓ 6.41% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 8.5B | ↓ 0.13% |
Total Liabilities | 3.6B | ↑ 0.69% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 8.6B | ↑ 0.28% |
Total Liabilities | 3.6B | ↓ 0.43% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 6.7B | ↓ 21.72% |
Total Liabilities | 3.4B | ↓ 4.54% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 136.3M | ↑ 392.06% |
Investing Cash Flow | 115.0M | ↓ 126.62% |
Financing Cash Flow | -244.1M | ↓ 190.19% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 134.5M | ↓ 1.36% |
Investing Cash Flow | -27.2M | ↓ 123.69% |
Financing Cash Flow | -98.3M | ↓ 59.73% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 629.8M | ↑ 368.28% |
Investing Cash Flow | -63.3M | ↑ 132.55% |
Financing Cash Flow | -130.3M | ↑ 32.55% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 805.9M | ↑ 27.96% |
Investing Cash Flow | -319.5M | ↑ 404.61% |
Financing Cash Flow | -173.2M | ↑ 32.93% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 885.3M | ↑ 9.86% |
Investing Cash Flow | -1.6B | ↑ 414.57% |
Financing Cash Flow | 252.0M | ↓ 245.52% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 169.4M | ↓ 1846.39% |
Investing Cash Flow | -59.3M | ↑ 98.99% |
Financing Cash Flow | -31.7M | ↓ 74.84% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 188.9M | ↑ 11.51% |
Investing Cash Flow | -68.9M | ↑ 16.19% |
Financing Cash Flow | -59.6M | ↑ 88.01% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -30.6M | ↓ 116.2% |
Investing Cash Flow | -42.3M | ↓ 38.61% |
Financing Cash Flow | -99.7M | ↑ 67.28% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 41.5M | ↓ 235.62% |
Investing Cash Flow | -21.3M | ↓ 49.65% |
Financing Cash Flow | -48.7M | ↓ 51.15% |
Sell
Neutral
Buy
Quidelortho Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Quidelortho Corp | 13.27% | -45.65% | -56.67% | -72.63% | -35.03% |
![]() Stryker Corporation | -3.84% | 5.16% | 12.86% | 24.25% | 52.69% |
![]() Boston Scientific Corp. | -3.68% | 21.48% | 41.72% | 68.89% | 76.47% |
![]() Edwards Lifesciences Corp. | -34.8% | -18.49% | -34.85% | -45.17% | -15.86% |
![]() Abbott Laboratories | 1.03% | -5.4% | -7.12% | -11.35% | 20.75% |
![]() Medtronic Plc | -1.99% | -9.34% | -13.21% | -38.74% | -23.49% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Quidelortho Corp | 9.72 | NA | 7.19 | 1.96 | -0.43 | 0.01 | NA | 49.52 |
![]() Stryker Corporation | 38.91 | 38.91 | 2.92 | 11.95 | 0.19 | 0.07 | 0.01 | 50.33 |
![]() Boston Scientific Corp. | 63.22 | 63.22 | 1.8 | 2.37 | 0.09 | 0.05 | NA | 13.16 |
![]() Edwards Lifesciences Corp. | 36.4 | 36.4 | 5.19 | 2.76 | 0.22 | 0.12 | NA | 12.35 |
![]() Abbott Laboratories | 33.84 | 33.84 | 5.99 | 4.66 | 0.15 | 0.06 | 0.02 | 22.31 |
![]() Medtronic Plc | 28.97 | 28.97 | 1.52 | 5.2 | 0.07 | 0.04 | 0.04 | 38.29 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Quidelortho Corp | Buy | $2.6B | -35.03% | 9.72 | -61.65% |
![]() Stryker Corporation | Buy | $129.7B | 52.69% | 38.91 | 16.03% |
![]() Boston Scientific Corp. | Buy | $114.3B | 76.47% | 63.22 | 12.05% |
![]() Edwards Lifesciences Corp. | Buy | $52.4B | -15.86% | 36.4 | 23.74% |
![]() Abbott Laboratories | Buy | $186.6B | 20.75% | 33.84 | 13.65% |
![]() Medtronic Plc | Buy | $102.5B | -23.49% | 28.97 | 11.36% |
Insights on Quidelortho Corp
Revenue is down for the last 3 quarters, 744.0M → 709.7M (in $), with an average decrease of 2.3% per quarter
Netprofit is down for the last 2 quarters, 7.0M → -1.70B (in $), with an average decrease of 24471.4% per quarter
In the last 1 year, Boston Scientific Corp. has given 41.7% return, outperforming this stock by 98.4%
In the last 3 years, Boston Scientific Corp. has given 68.9% return, outperforming this stock by 141.5%
The Carlyle Group Inc
T. Rowe Price Investment Management,Inc.
Vanguard Group Inc
BlackRock Inc
Rubric Capital Management LP
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
QuidelOrtho Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.
Organization | Quidelortho Corp |
Employees | 7100 |
CEO | Mr. Michael S. Iskra |
Industry | Health Technology |
Outfront Media Inc.
$38.24
-0.42%
Blackrock Short Duration Bond Etf
$38.24
-0.42%
Moog Inc
$38.24
-0.42%
Edgio Inc.
$38.24
-0.42%
Invesco S&p 500 Momentum Etf
$38.24
-0.42%
Silicon Laboratories Inc
$38.24
-0.42%
Helmerich & Payne, Inc.
$38.24
-0.42%
Crane Nxt Co
$38.24
-0.42%
Liberty Global Plc - Class C Shares
$38.24
-0.42%